We are live on ! Find out more
OPK icon

Opko Health

221 hedge funds and large institutions have $214M invested in Opko Health in 2022 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 60 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more call options, than puts

Call options by funds: $3.87M | Put options by funds: $2.12M

7% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 60

0% more funds holding

Funds holding: 221221 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 33

0.69% less ownership

Funds ownership: 23.97%23.28% (-0.69%)

39% less capital invested

Capital invested by funds: $350M → $214M (-$136M)

Holders
221
Holders Change
Holders Change %
0%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
33
Increased
64
Reduced
60
Closed
33
Calls
$3.87M
Puts
$2.12M
Net Calls
+$1.75M
Net Calls Change
+$4.63M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$51.4M +$1.32M +835,721 +2%
BlackRock
2
BlackRock
New York
$44.3M +$1.53M +968,918 +3%
State Street
3
State Street
Massachusetts
$13.1M +$112K +71,045 +0.7%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$9.98M +$249K +158,178 +2%
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$7.23M -$287K -182,129 -3%
Charles Schwab
6
Charles Schwab
California
$5.47M +$884K +561,093 +15%
Northern Trust
7
Northern Trust
Illinois
$4.82M -$82K -52,062 -1%
Goldman Sachs
8
Goldman Sachs
New York
$4.73M +$1.54M +979,242 +35%
Millennium Management
9
Millennium Management
New York
$4.65M +$2.49M +1,578,263 +74%
Norges Bank
10
Norges Bank
Norway
$4.04M
OIM
11
Oracle Investment Management
Connecticut
$4.04M -$2.95M -1,872,468 -37%
N
12
Nuveen
North Carolina
$3.05M +$377K +239,428 +11%
Deutsche Bank
13
Deutsche Bank
Germany
$2.9M +$63.6K +40,332 +2%
Renaissance Technologies
14
Renaissance Technologies
New York
$2.86M -$866K -549,800 -19%
Two Sigma Investments
15
Two Sigma Investments
New York
$2.84M -$974K -618,353 -21%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$2.83M +$222K +140,600 +7%
Citigroup
17
Citigroup
New York
$2.67M -$15.6K -9,909 -0.5%
N
18
Numerai
California
$2.36M +$2.98M +1,890,727 New
VOYA Investment Management
19
VOYA Investment Management
Georgia
$2.06M +$37.1K +23,537 +1%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$1.93M -$793K -502,924 -25%
JP Morgan Chase
21
JP Morgan Chase
New York
$1.6M -$1.73M -1,095,358 -46%
Nordea Investment Management
22
Nordea Investment Management
Sweden
$1.52M -$40.9K -25,972 -2%
Swiss National Bank
23
Swiss National Bank
Switzerland
$1.51M +$259K +164,355 +16%
Bank of America
24
Bank of America
North Carolina
$1.42M +$1.56M +990,274 +662%
Morgan Stanley
25
Morgan Stanley
New York
$1.37M -$395K -250,945 -19%

OPK Hedge Fund Activity: Q4 2022 in Review

221 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q4 2022, worth a combined $214M — down 39% from $350M a quarter earlier.

Fund positioning in OPK was balanced in Q4 2022: 33 funds opened new positions, 33 closed out, 64 added to existing stakes and 60 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.49M. The largest seller was Invesco, cutting an estimated $4.17M.

  • 221 institutional investors held Opko Health (OPK) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $214M of Opko Health stock for Q4 2022, down 39% quarter-over-quarter.
  • 33 funds opened new Opko Health positions in Q4 2022 and 33 closed out, a net change of 0 holders.
  • The largest Opko Health buyer in Q4 2022 was Millennium Management, an estimated $2.49M added.
  • The largest Opko Health seller in Q4 2022 was Invesco, an estimated $4.17M sold.

Based on aggregated 13F filings for Q4 2022.